Albemarle shifts focus to lithium, poised for growth with strong assets and $2.7B liquidity

Albemarle has transformed into a pure-play lithium and bromine company after divesting its catalyst business and improving its balance sheet. The company holds top-tier lithium assets, securing a low-cost position and structural advantages, supported by $2.7 billion in liquidity. With lithium prices recovering and controlled supply, Albemarle projects an EBITDA of around $2.5 billion, with potential growth from Kings Mountain and direct lithium extraction expansions. This positions Albemarle as a speculative buy for investors willing to tolerate risk and wait for lithium price gains.